ICON plc (NASDAQ: ICLR) has released its ICON Cares 2023 Report, outlining its achievements in environmental, social, and governance (ESG), diversity and inclusion, and corporate social responsibility (CSR).
The report highlights ICON’s efforts to enhance the impact of its clinical research services. It has leveraged technology and partnerships to increase patient access to clinical trials and advance healthcare equity. The company’s recent initiatives include launching an updated digital platform to streamline patient services and joining the Beacon of Hope collaboration to address health disparities.
ICON’s commitment to diversity and inclusion extends to its workplace. As of 2023, 44% of employees at the vice president level and above were female, moving towards a goal of 50% by 2025. The company’s new IMentor Program provides support for career development within underrepresented groups.
ICON has also prioritized sustainable business practices. It has submitted science-based targets for environmental sustainability and made progress towards its environmental goals.
Beyond its core business, ICON supports communities through corporate giving, employee engagement, and academic partnerships. It established a Charity Matching Program, funded scholarships for STEM students, and collaborated with educational institutions to enhance science and technology education.
The report has earned recognition for ICON’s efforts. In 2023, the company received a gold medal status from EcoVadis for business sustainability and a B score on its CDP Climate Change response, up from a C in 2022. It has also been named one of Europe’s Climate Leaders in 2024 by the Financial Times and Statista.
ICON’s CEO, Dr. Steve Cutler, emphasized the significance of these achievements: “Our people’s talent and passion drive our positive impact. We will continue to make progress towards our priorities, enhancing public health, promoting diversity, and operating sustainably.”
Source link: http://www.businesswire.com/news/home/20240509274727/en/ICON-releases-its-ICON-Cares-2023-Report
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
